CAR-T cell therapy in gastrointestinal tumors and hepatic carcinoma: From bench to bedside.
about
CAR-T cell therapy in ovarian cancer: from the bench to the bedside.Trial Watch: Adoptively transferred cells for anticancer immunotherapy.Folate receptor 1 (FOLR1) targeted chimeric antigen receptor (CAR) T cells for the treatment of gastric cancer.Emerging Therapies in the Management of Advanced-Stage Gastric CancerPharmacologically upregulated carcinoembryonic antigen-expression enhances the cytolytic activity of genetically-modified chimeric antigen receptor NK-92MI against colorectal cancer cells
P2860
CAR-T cell therapy in gastrointestinal tumors and hepatic carcinoma: From bench to bedside.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 October 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
CAR-T cell therapy in gastroin ...... cinoma: From bench to bedside.
@en
CAR-T cell therapy in gastroin ...... cinoma: From bench to bedside.
@nl
type
label
CAR-T cell therapy in gastroin ...... cinoma: From bench to bedside.
@en
CAR-T cell therapy in gastroin ...... cinoma: From bench to bedside.
@nl
prefLabel
CAR-T cell therapy in gastroin ...... cinoma: From bench to bedside.
@en
CAR-T cell therapy in gastroin ...... cinoma: From bench to bedside.
@nl
P2093
P2860
P1433
P1476
CAR-T cell therapy in gastroin ...... cinoma: From bench to bedside.
@en
P2093
Meiyu Peng
Rongxin Zhang
Zhenyi Xue
Zimu Zhang
P2860
P304
P356
10.1080/2162402X.2016.1251539
P577
2016-10-28T00:00:00Z